Chicago, IL (PRWEB) February 28, 2012
Clopton Capital, a provider of business loans, working capital and SBA loans is announcing the arrival fixed rates on both SBA 504 and SBA 7a loans. These small business loans are believed by the firm to be more advantageous and less risky for the borrower since it will be easier to predict the total cost of borrowing business capital or working capital on a fixed SBA loan. They believe this will help drive more business to their firm that they had previously been unable to acquire. This announcement is being made via their SBA loan website, SBABusinessLoanSource.com, CloptonCapital.com and this press release. They believe that it is necessary to establish themselves as soon as possible as a source for fixed interest rate working capital business loans since they believe many of their competitors are soon to do the same. “Being able to provide fixed interest rate SBA loans is definitely a breakthrough for us. I can safely say that this change will benefit us and even more so our clients”, said Jake Clopton, the founder of Clopton Capital.
Clopton Capital states that these fixed interest rate SBA loans have been made available roughly one week before the publishing of this release and that they are fully capable of accepting new SBA loan requests immediately. “This is really exciting to be able to offer these SBA loans as there have been few times in history when they were needed more. I imagine there will be a significant spike in business immediately following our current prospects and clients learning of this”, said Matt Reed, an associate of Clopton Capital.
For more information about Clopton Capital’s business loan services visit their website dedicated to them at CloptonCapital.com. To join their financial link exchange visit CloptonCapital.com/link.
http://tourism9.com/ http://vkins.com/
2012年1月12日星期四
Cascadia Capital Announced as Winner for the 10th Annual M&A Awards
SEATTLE, WA–(Marketwire -01/11/12)- Cascadia Capital, a diversified, boutique investment bank serving both private and public growth companies around the globe, today announced that it was named the winner of the 10th Annual M&A Advisor Award in the Industrial Manufacturing/Distribution ($50 Million to under $250 Million) category. M&A Advisor recognized Cascadia for its role in advising Interstate Distributor Co. (Interstate) in its acquisition by Saltchuk Resources in May 2011.
“Cascadia represents the best of the M&A industry in 2011 and earned these honors by standing out in a group of very impressive finalists,” said Roger Aguinaldo, CEO and Founder of The M&A Advisor. “Cascadia was chosen from 389 nominations and over 500 participating companies by an independent body of expert judges that span the M&A industry.”
“Saltchuk’s acquisition of Interstate proved to be a landmark transaction in 2012, demonstrating both the significant growth opportunities in the transportation industry with the upswing in the economy, and the much improved M&A markets for companies throughout the middle market in the Pacific Northwest, where both of these companies were based,” said Christian Schiller, Managing Director of the Middle Market practice at Cascadia Capital. “The deal showcases Cascadia’s proven transaction expertise and relationships in the industry, and our in-depth understanding of the dynamics shaping the middle market sectors in the Pacific Northwest. This award recognizes this deep dive expertise, as well as the efforts and acumen of Saltchuk’s and Interstate’s management teams and other transactional advisors.”
Since 1998, The M&A Advisor has been presenting, recognizing the achievement of and facilitating connections between the world’s leading mergers and acquisitions, financing and turnaround professionals with a comprehensive range of services including M&A SUMMITS; M&A AWARDS; M&A CONNECTS™; M&A ALERTS™, M&A LINKS™ and M&A MARKET INTEL™. The Annual M&A Advisor Awards celebrate the accomplishments of the top M&A professionals in the United States, and recognize the M&A Advisor Lifetime Achievement Award winners with their induction into the Hall of Fame. To learn more visit: www.maadvisor.com.
For a complete list of the winners please click here: http://www.maadvisor.net/conferences/2011-many/10th_annual_MA_Advisor_Awards-press-release.pdf
About Cascadia Capital, LLCCascadia Capital is a diversified, boutique investment bank serving both private and public growth companies around the globe. Cascadia’s business is diversified in terms of the industries the firm covers — Information Technology, Sustainable Industries and Middle Market — and in terms of the range of advisory services it provides — Mergers and Acquisitions, Corporate Financing and Strategic Advising. This diversification provides the firm with stability amidst market fluctuations. Cascadia is a pure advisory firm, and unlike other investment banks, is not conflicted by trading, lending, research or cross selling business. For over a decade, the firm has delivered the best outcomes for clients based on its transaction experience, domain expertise and commitment to building long-term relationships. Cascadia always acts in the long-term interests of clients, and honors its position as a trusted advisor. For more information, visit http://www.cascadiacapital.com/
http://tourism9.com/
“Cascadia represents the best of the M&A industry in 2011 and earned these honors by standing out in a group of very impressive finalists,” said Roger Aguinaldo, CEO and Founder of The M&A Advisor. “Cascadia was chosen from 389 nominations and over 500 participating companies by an independent body of expert judges that span the M&A industry.”
“Saltchuk’s acquisition of Interstate proved to be a landmark transaction in 2012, demonstrating both the significant growth opportunities in the transportation industry with the upswing in the economy, and the much improved M&A markets for companies throughout the middle market in the Pacific Northwest, where both of these companies were based,” said Christian Schiller, Managing Director of the Middle Market practice at Cascadia Capital. “The deal showcases Cascadia’s proven transaction expertise and relationships in the industry, and our in-depth understanding of the dynamics shaping the middle market sectors in the Pacific Northwest. This award recognizes this deep dive expertise, as well as the efforts and acumen of Saltchuk’s and Interstate’s management teams and other transactional advisors.”
Since 1998, The M&A Advisor has been presenting, recognizing the achievement of and facilitating connections between the world’s leading mergers and acquisitions, financing and turnaround professionals with a comprehensive range of services including M&A SUMMITS; M&A AWARDS; M&A CONNECTS™; M&A ALERTS™, M&A LINKS™ and M&A MARKET INTEL™. The Annual M&A Advisor Awards celebrate the accomplishments of the top M&A professionals in the United States, and recognize the M&A Advisor Lifetime Achievement Award winners with their induction into the Hall of Fame. To learn more visit: www.maadvisor.com.
For a complete list of the winners please click here: http://www.maadvisor.net/conferences/2011-many/10th_annual_MA_Advisor_Awards-press-release.pdf
About Cascadia Capital, LLCCascadia Capital is a diversified, boutique investment bank serving both private and public growth companies around the globe. Cascadia’s business is diversified in terms of the industries the firm covers — Information Technology, Sustainable Industries and Middle Market — and in terms of the range of advisory services it provides — Mergers and Acquisitions, Corporate Financing and Strategic Advising. This diversification provides the firm with stability amidst market fluctuations. Cascadia is a pure advisory firm, and unlike other investment banks, is not conflicted by trading, lending, research or cross selling business. For over a decade, the firm has delivered the best outcomes for clients based on its transaction experience, domain expertise and commitment to building long-term relationships. Cascadia always acts in the long-term interests of clients, and honors its position as a trusted advisor. For more information, visit http://www.cascadiacapital.com/
http://tourism9.com/
2012年1月4日星期三
Morgan Joseph TriArtisan Adds Two Managing Directors to Its Healthcare Investment Banking Group
NEW YORK–(BUSINESS WIRE)– Morgan Joseph TriArtisan LLC, the investment and merchant bank focused on middle market companies, today announced the addition of two new Managing Directors, John Cramer and Andy Sherman, to its Healthcare Investment Banking Group, reporting to Group Head Marc Cabrera.
Mr. Cramer, has over 15 years of experience working with companies in the Specialty Pharmaceuticals, Healthcare IT and Healthcare Services subsectors, including completed engagements for equity and debt financing, M&A and restructuring. Since 1996 he has completed over 115 transactions having an aggregate value in excess of $20 billion.
Mr. Sherman has over 17 years of M&A expertise with a focus on Healthcare Services, Specialty Pharmaceuticals and Medical Devices. He has completed over 90 transactions with an aggregate value in excess of $35 billion.
“The addition of John and Andy to our existing team bolsters our already strong presence in healthcare and underscores our firm’s commitment to continued growth,” said Mary Lou Malanoski, Morgan Joseph TriArtisan’s Vice Chair and Head of Investment Banking. “Their industry expertise, extensive relationships and diverse skills are a complement to our firm’s focus on providing differentiated, high-value services to the middle market. We believe Morgan Joseph TriArtisan is increasingly well positioned to serve this market with a solid core of professionals, and we are delighted to have John and Andy join our firm.
“Current conditions in the securities business provide us with the opportunity to add exceptionally qualified investment bankers like John and Andy, at a time when many of our competitors are reducing their staffs. Morgan Joseph TriArtisan is committed to continue building capabilities in our four core industry verticals in order to better serve our investment banking clients.”
Previously, Mr. Cramer spent nine years at Gleacher & Company covering Healthcare, where he successfully completed lead-managed initial public offerings and follow-on equity offerings, private placements of debt and equity, buy-side and sell-side M&A transactions and creditor and debtor-side restructurings. Earlier, he covered Healthcare IT and services at Robertson, Stephens & Company and was an associate at Dewey Ballantine LLP in New York City. He holds a Juris Doctor from The University of Michigan Law School and a BA from Albion College and Oxford University.
Prior to joining Morgan Joseph TriArtisan, Mr. Sherman was a senior member of the Healthcare Investment Banking Group at Madison Williams. From 2007 to 2009, Mr. Sherman worked in principal investing for KBL Healthcare Acquisition Corp. and Capitol Acquisition Corp., sourcing and executing transactions across various industries including healthcare services, specialty pharmaceuticals, and medical devices. From 2001 to 2007, Mr. Sherman was at Banc of America Securities where he was a Principal in Investment Banking. Earlier, Mr. Sherman worked at Montgomery Securities and James D. Wolfensohn, Inc. Mr. Sherman received a Masters of Business Administration with Distinction from Harvard Business School, a B.S. in Economics from the Wharton School of Business and a B.A. in International Relations from the University of Pennsylvania.
About Morgan Joseph TriArtisan LLC
Morgan Joseph TriArtisan LLC (www.mjta.com) is an investment and merchant bank engaged in providing financial advice, capital raising and private equity investing. The firm’s services include mergers, acquisitions and restructuring advice, in addition to private placements and public offerings of equity and debt, as well as research for institutional clients
http://tourism9.com/
Mr. Cramer, has over 15 years of experience working with companies in the Specialty Pharmaceuticals, Healthcare IT and Healthcare Services subsectors, including completed engagements for equity and debt financing, M&A and restructuring. Since 1996 he has completed over 115 transactions having an aggregate value in excess of $20 billion.
Mr. Sherman has over 17 years of M&A expertise with a focus on Healthcare Services, Specialty Pharmaceuticals and Medical Devices. He has completed over 90 transactions with an aggregate value in excess of $35 billion.
“The addition of John and Andy to our existing team bolsters our already strong presence in healthcare and underscores our firm’s commitment to continued growth,” said Mary Lou Malanoski, Morgan Joseph TriArtisan’s Vice Chair and Head of Investment Banking. “Their industry expertise, extensive relationships and diverse skills are a complement to our firm’s focus on providing differentiated, high-value services to the middle market. We believe Morgan Joseph TriArtisan is increasingly well positioned to serve this market with a solid core of professionals, and we are delighted to have John and Andy join our firm.
“Current conditions in the securities business provide us with the opportunity to add exceptionally qualified investment bankers like John and Andy, at a time when many of our competitors are reducing their staffs. Morgan Joseph TriArtisan is committed to continue building capabilities in our four core industry verticals in order to better serve our investment banking clients.”
Previously, Mr. Cramer spent nine years at Gleacher & Company covering Healthcare, where he successfully completed lead-managed initial public offerings and follow-on equity offerings, private placements of debt and equity, buy-side and sell-side M&A transactions and creditor and debtor-side restructurings. Earlier, he covered Healthcare IT and services at Robertson, Stephens & Company and was an associate at Dewey Ballantine LLP in New York City. He holds a Juris Doctor from The University of Michigan Law School and a BA from Albion College and Oxford University.
Prior to joining Morgan Joseph TriArtisan, Mr. Sherman was a senior member of the Healthcare Investment Banking Group at Madison Williams. From 2007 to 2009, Mr. Sherman worked in principal investing for KBL Healthcare Acquisition Corp. and Capitol Acquisition Corp., sourcing and executing transactions across various industries including healthcare services, specialty pharmaceuticals, and medical devices. From 2001 to 2007, Mr. Sherman was at Banc of America Securities where he was a Principal in Investment Banking. Earlier, Mr. Sherman worked at Montgomery Securities and James D. Wolfensohn, Inc. Mr. Sherman received a Masters of Business Administration with Distinction from Harvard Business School, a B.S. in Economics from the Wharton School of Business and a B.A. in International Relations from the University of Pennsylvania.
About Morgan Joseph TriArtisan LLC
Morgan Joseph TriArtisan LLC (www.mjta.com) is an investment and merchant bank engaged in providing financial advice, capital raising and private equity investing. The firm’s services include mergers, acquisitions and restructuring advice, in addition to private placements and public offerings of equity and debt, as well as research for institutional clients
http://tourism9.com/
订阅：
博文 (Atom)